Exact Sciences (EXAS) Stock Chart & Stock Price History $58.48 -0.92 (-1.55%) (As of 10:46 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exact Sciences Stock Price Performance 5 Day Performance+3.52%1 Month Performance+12.27%3 Month Performance-14.70%6 Month Performance+32.44%Year-To-Date Performance-19.71%1 Year Performance-19.19% Receive EXAS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 EXAS Stock Chart for Monday, December, 23, 2024 EXAS Chart by TradingView Exact Sciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$56.11$59.40+5.86%$59.70$55.983.27 million shs$10.99 billion12/19/2024$57.38$56.11-2.21%$57.44$55.652.06 million shs$10.38 billion12/18/2024$60.37$57.38-4.95%$60.62$57.192.09 million shs$10.62 billion12/17/2024$60.75$60.37-0.63%$62.15$60.192.31 million shs$11.17 billion12/16/2024$61.25$60.75-0.82%$61.92$60.231.69 million shs$11.24 billion12/13/2024$62.51$61.25-2.02%$63.10$60.611.48 million shs$11.34 billion Get the Latest News and Ratings for EXAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$63.16$62.51-1.03%$64.55$62.482.23 million shs$11.57 billion12/11/2024$61.58$63.16+2.57%$63.89$61.731.77 million shs$11.69 billion12/10/2024$61.80$61.58-0.36%$63.21$61.281.49 million shs$11.40 billion12/09/2024$62.46$61.80-1.06%$63.84$61.801.34 million shs$11.44 billion12/06/2024$62.61$62.46-0.24%$64.32$62.252.26 million shs$11.56 billion12/05/2024$64.14$62.61-2.39%$64.77$62.021.90 million shs$11.59 billion12/04/2024$60.56$64.14+5.91%$64.56$60.622.63 million shs$11.87 billion12/03/2024$61.69$60.56-1.83%$62.26$60.522.55 million shs$11.21 billion12/02/2024$62.08$61.69-0.63%$61.85$60.111.80 million shs$11.42 billion11/29/2024$61.69$62.08+0.63%$62.28$61.151.25 million shs$11.49 billion11/28/2024$61.69$61.69$61.95$59.872.50 million shs$11.42 billion11/27/2024$60.10$61.69+2.65%$61.95$59.872.50 million shs$11.42 billion11/26/2024$55.14$60.10+9.00%$61.22$57.805.86 million shs$9.79 billion11/25/2024$52.91$55.14+4.21%$55.38$52.813.09 million shs$10.21 billion11/22/2024$53.39$52.91-0.90%$54.26$52.792.00 million shs$9.79 billion Related Companies Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Neurocrine Biosciences Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Exelixis Stock Price Chart Repligen Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Halozyme Therapeutics Stock Price Chart Receive EXAS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXAS) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredCackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America b...DTI | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But her...Insiders Exposed | SponsoredIf you see ONE chart today… make it this one$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Go...ProsperityPub | Sponsored70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all po...WealthPress | SponsoredHow Low-Cost Stocks Generate Monthly IncomeAre you ready to transform your investment strategy and generate a steady monthly income? We’re excited to ...Darwin | SponsoredVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formu...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
